- My News
- All News
- Most Popular
Research shows that COVID-19 derailed annual checkups. Breast cancer screenings declined 87% in April 2020 compared to 5-year averages for that month.
1 in 3 women are diagnosed with breast cancer annually. Of that cohort, 8 out of 9 have no family history of the disease. Experts say early detection remains the best defense.
"Successful treatment and survival rates for breast cancer patients are dramatically affected by early detection," says Dr. John Feller, Chief Medical Officer at HALO Diagnostics. He adds, "The 5-year survival rate is almost 100%."
HALO Diagnostics provides women with personalized care and precision diagnostics at its California centers including HALO Breast Care Center in Chico, Silicon Valley MRI in Silicon Valley, Palms Imaging Center in Oxnard. They also have four Precision Imaging Centers in and around Jacksonville, Florida.
Advanced Imaging includes:
Patients need follow-up tests when abnormalities are spotted during screening.
About HALO Diagnostics
At HALO Diagnostics (HALO Dx), we recognize every patient is unique. Our focus is early detection and precision-focused healthcare, preventing, and conquering diseases that have a geometric impact on patient outcomes. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarker tests, and community-based data at scale combined with deep learning algorithms. By optimizing these solutions under the HALO Dx platform, we provide precise, actionable results to enable life-changing treatments by physicians for their patients.
HALO Diagnostics is a pioneer and recognized market leader in men's and women's health.
SOURCE HALO Diagnostics
Did you like this article?